PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $79,000 | +2.6% | 30,932 | +0.3% | 0.00% | – |
| Q4 2020 | $77,000 | +26.2% | 30,851 | +4.0% | 0.00% | – |
| Q3 2020 | $61,000 | -35.1% | 29,667 | -2.2% | 0.00% | – |
| Q2 2020 | $94,000 | +51.6% | 30,341 | +10.7% | 0.00% | – |
| Q1 2020 | $62,000 | -41.0% | 27,398 | -5.5% | 0.00% | – |
| Q4 2019 | $105,000 | +5.0% | 28,980 | -0.8% | 0.00% | – |
| Q3 2019 | $100,000 | -27.5% | 29,225 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $138,000 | +24.3% | 29,429 | -11.1% | 0.00% | – |
| Q1 2019 | $111,000 | +22.0% | 33,111 | -3.1% | 0.00% | – |
| Q4 2018 | $91,000 | -52.8% | 34,184 | -0.8% | 0.00% | -100.0% |
| Q3 2018 | $193,000 | +12.9% | 34,447 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $171,000 | -2.3% | 33,826 | +32.1% | 0.00% | 0.0% |
| Q1 2018 | $175,000 | -3.8% | 25,600 | +6.4% | 0.00% | 0.0% |
| Q4 2017 | $182,000 | +36.8% | 24,069 | +4.5% | 0.00% | – |
| Q3 2017 | $133,000 | +23.1% | 23,026 | +8.1% | 0.00% | – |
| Q2 2017 | $108,000 | – | 21,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |